Infectious diseases and pathogens have caught people’s attention again but will funding be a blip or reshape the healthcare industry? And the healthcare opportunities go further into telemedicine and other mental and physical treatments affected by the crisis after all.
Month: May 2020
ADC Therapeutics adds to IPO
The oncology therapeutics developer, a spinoff from Spirogen, has increased the size of its initial public offering from almost $233m to nearly $268m.
SoftBank caters to Katerra with $200m
SoftBank Vision Fund has invested $200m in the construction services provider, which announced the round at the same time as chief operating officer Paal Kibsgaard’s ascendancy to CEO.
Rallybio tallies up $145m for series B
The rare disease drug developer pulled in $145m through a round led by Pivotal BioVenture Partners and backed by Mitsui and Fidelity.
Vroom speeds to $100m IPO filing
AutoNation-backed online car dealership Vroom has filed to raise up to $100m, five months after a series H round valuing it at $1.5bn.
Yigongli cleans up in series C round
The Alibaba-backed automated car wash service has completed an $84.4m round, with People’s Insurance Company of China supplying a third of the money.
Cyberbit seizes $70m from Charlesbank
Elbit Systems is now a minority shareholder in cybersecurity training spinoff Cyberbit, which has received primary and secondary funding from Charlesbank Technology Opportunities Fund.
GO1 gets $40m in series C funding
The online training service, which has seen engagement triple in the past month, raised $40m in a round co-led by Seek and backed by M12 and Salesforce Ventures.
SQZ sequences $65m series D
GV and Illumina Ventures returned to reinvest in cellular therapy developer SQZ Biotechnologies, which has now raised at least $166m to date.
Cortical Labs is building computer chips using biological neurons
Comment from Faisal Khan, editor, Technicity
Computers modelled on the human brain
Comment from Kai Beckmann, member, executive board, Merck KGaA
Brains light up with AI
AI supplement Q2 2020 editorial by James Mawson, editor in chief, Global Corporate Venturing
Hugo hatches $10m fund
Hugo, an on-demand delivery and services provider focused on Central America and the Caribbean, intends to channel up to $10m into the vehicle.
Gatt gets series B funding
Johnson & Johnson Innovation – JJDC was among the investors in an $11.7m round for blood sealant technology developer Gatt Technologies.